Abstract

The main active component present in turmeric is curcumin and is subsequently responsible for some of its therapeuticeffects. Turmeric, however, contains two other active molecules, namely demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC). Collectively, these three molecules are known as curcuminoids. Commercially available dietary supplements vary in these components. In this study the curcuminoids were analyzed using a reverse phase ion-pairing HPLC method. UV detection was used to detect the three curcuminoids at a single wavelength of 430 nm. The validation of the method was carried to ICH guidelines. Good repeatability of the method was achieved at concentrations of curcumin, DMC and BDMC equivalent to 136, 148 and 162 μM, respectively, with R.S.D. values of 2.25, 1.93 and 1.64%, respectively. Similarly, good reproducibility and linearity of the method was obtained for curcumin, DMC and BDMC. On completion of the validation, 10 commercially available turmeric dietary supplements were analyzed for their curcuminoid content. Results showed two of the turmeric dietary supplements to contain near pure curcumin. The other supplements tested contained significant amounts of DMC and BDMC. Similarly, there was a significant increase in curcuminoid content between supplements that contained turmeric extract and those that contained raw turmeric. Interestingly, supplements containing turmeric extract contained a significantly higher proportion of curcumin compared to DMC and BDMC, reflected in the ratio of curcumin: DMC: BDMC.

Highlights

  • A variety of different curcuminoids may be derived from the south Asian spice turmeric, all with slightly different chemical compositions

  • This study investigates a high performance liquid chromatography (HPLC) method for the separation of the three principle

  • The results showed that the purity of 5 mg% of curcumin, DMC and BDMC were 98.7, 99.7 and 95.1%, respectively

Read more

Summary

Introduction

A variety of different curcuminoids may be derived from the south Asian spice turmeric, all with slightly different chemical compositions. The main curcuminoids contained within turmeric are curcumin, demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC) (Figure 1). These three derivatives exhibit differing levels of therapeutic activity [1]. BDMC has been shown to exhibit a greater cytotoxicity against ovarian cancer cells compared to DMC and curcumin [2]. The therapeutic effects that curcuminoids generate through anti-oxidant and anti-inflammatory properties appear to be much more pronounced in curcumin and DMC compared with that of BDMC [3]. It has been shown that BDMC is a less potent inhibitor of inflammation due to its relatively reduced ability to inhibit the transcription of cyclooxygenase enzymes compared with curcumin and DMC [4]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call